Citadel Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$368K Sell
15,606
-139,552
-90% -$3.56M ﹤0.01% 10004
2025
Q4
$4.51M Sell
155,158
-22,110
-12% -$566K ﹤0.01% 4444
2025
Q3
$3.34M Buy
177,268
+31,775
+22% +$501K ﹤0.01% 5110
2025
Q2
$2.04M Sell
145,493
-164,582
-53% -$2.31M ﹤0.01% 5666
2025
Q1
$4.85M Buy
310,075
+220,907
+248% +$3.11M ﹤0.01% 3926
2024
Q4
$1.24M Sell
89,168
-2,941,905
-97% -$32.2M ﹤0.01% 6577
2024
Q3
$28.2M Buy
3,031,073
+98,426
+3% +$971K 0.03% 1730
2024
Q2
$27.3M Buy
2,932,647
+1,018,377
+53% +$9.21M 0.03% 1691
2024
Q1
$19M Buy
+1,914,270
New +$14.3M 0.02% 2122
2023
Q4
Sell
-250,535
Closed -$681K 14233
2023
Q3
$1.33M Buy
250,535
+196,127
+360% +$1.67M ﹤0.01% 6005
2023
Q2
$519K Sell
54,408
-217,113
-80% -$2.41M ﹤0.01% 7855
2023
Q1
$2.99M Buy
271,521
+261,888
+2,719% +$3.79M ﹤0.01% 4639
2022
Q4
$143K Sell
9,633
-70,882
-88% -$1.24M ﹤0.01% 10684
2022
Q3
$1.54M Sell
80,515
-111,996
-58% -$2.54M ﹤0.01% 6105
2022
Q2
$4.1M Buy
192,511
+15,811
+9% +$324K 0.01% 4163
2022
Q1
$3.4M Sell
176,700
-70,215
-28% -$1.19M ﹤0.01% 4923
2021
Q4
$5.12M Sell
246,915
-19,017
-7% -$379K 0.01% 4246
2021
Q3
$6.35M Sell
265,932
-175,580
-40% -$4M 0.01% 3857
2021
Q2
$12M Sell
441,512
-10,944
-2% -$308K 0.01% 2800
2021
Q1
$13.1M Buy
452,456
+318,753
+238% +$9.95M 0.01% 2577
2020
Q4
$3.76M Buy
133,703
+118,353
+771% +$2.9M ﹤0.01% 4181
2020
Q3
$450K Sell
15,350
-17,739
-54% -$474K ﹤0.01% 7479
2020
Q2
$1M Sell
33,089
-22,476
-40% -$650K ﹤0.01% 5826
2020
Q1
$1.66M Buy
+55,565
New +$1.49M ﹤0.01% 4454

Other funds holding ARQT